Menlo Therapeutics (MNLO) IPO Opens Up 21%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Menlo Therapeutics Inc. (MNLO) Prices 7M Share IPO at $17/Sh
January 25, 2018 5:45 AM ESTMenlo Therapeutics Inc. (NASDAQ: MNLO) today announced the pricing of the Companys initial public offering of 7,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts. All of the shares of common stock are being offered by... More
